5-PAHSA
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


5-PAHSA
Description:
5-PAHSA increases insulin sensitivity, and has orally active anti-inflammatory and neuroprotective effects in mice HFD-induced diabetes mice. 5-PAHSA can be used for research of neurological dysfunction in diabetics[1][2][3].Product Name Alternative:
trans-PX-102, (-)-PX-102 (trans isomer); (-)-PX-104, PX-111, ABR-215757-d5-1; ABR 25757-d5-1UNSPSC:
12352211Hazard Statement:
H302-H315-H319-H331-H336-H351-H361-H372-H412Target:
Endogenous MetaboliteType:
Reference compoundRelated Pathways:
Metabolic Enzyme/ProteaseApplications:
Metabolism-sugar/lipid metabolismField of Research:
Metabolic Disease; Inflammation/Immunology; Neurological DiseaseAssay Protocol:
https://www.medchemexpress.com/5-pahsa.htmlConcentration:
10mMPurity:
98.08Solubility:
DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 80°C)Smiles:
OC(CCCC(CCCCCCCCCCCCC)OC(CCCCCCCCCCCCCCC)=O)=OMolecular Formula:
C34H66O4Molecular Weight:
538.89Precautions:
P260-P261-P264-P270-P271-P273-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501References & Citations:
[1]Wang JT, et al. A novel palmitic acid hydroxy stearic acid (5-PAHSA) plays a neuroprotective role by inhibiting phosphorylation of the m-TOR-ULK1 pathway and regulating autophagy. CNS Neurosci Ther. 2021 Apr;27 (4) :484-496.|[2]Paluchova V, et al. Lipokine 5-PAHSA Is Regulated by Adipose Triglyceride Lipase and Primes Adipocytes for De Novo Lipogenesis in Mice. Diabetes. 2020 Mar;69 (3) :300-312. |[3]Wang YM, et al. High Glucose Concentration Impairs 5-PAHSA Activity by Inhibiting AMP-Activated Protein Kinase Activation and Promoting Nuclear Factor-Kappa-B-Mediated Inflammation. Front Pharmacol. 2019 Jan 7;9:1491.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category:
Reference compound1Clinical Information:
No Development ReportedCAS Number:
[1481636-41-2]
